Cargando…

Primary angiosarcoma of breast: A case report and literature review

INTRODUCTION AND IMPORTANCE: Primary angiosarcoma of breast (PAB) is a rare and aggressive malignancy with limited published literature. This article aims to disclose the diagnosis and treatment of this case, review previous case reports, and provide clinical experience to breast surgeons. CASE PRES...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Min, Yin, Ke, Chen, Lin, Shang, Xingchen, Yang, Qing, Tian, Xingsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173155/
https://www.ncbi.nlm.nih.gov/pubmed/37120900
http://dx.doi.org/10.1016/j.ijscr.2023.108219
_version_ 1785039758756413440
author Li, Min
Yin, Ke
Chen, Lin
Shang, Xingchen
Yang, Qing
Tian, Xingsong
author_facet Li, Min
Yin, Ke
Chen, Lin
Shang, Xingchen
Yang, Qing
Tian, Xingsong
author_sort Li, Min
collection PubMed
description INTRODUCTION AND IMPORTANCE: Primary angiosarcoma of breast (PAB) is a rare and aggressive malignancy with limited published literature. This article aims to disclose the diagnosis and treatment of this case, review previous case reports, and provide clinical experience to breast surgeons. CASE PRESENTATION: A 36-year-old Asian female presented with a diffuse mass growing rapidly in her left breast. The ultrasonography (USG) suspected granulomatous mastitis. The core needle biopsy (CNB) confirmed the diagnosis of breast angiosarcoma (AS). She underwent mastectomy without axillary lymph node dissection (ALND) followed by adjuvant chemotherapy. About 11 months after mastectomy, the patient had bone metastasis. CLINICAL DISCUSSION: PAB is a rare vascular neoplasia, characterized by aggressive patterns, poor prognosis, and high malignant potential. It is difficult to diagnose or differentiate only by clinical or imaging examination. Biopsy and immunohistochemical staining are the most reliable method. Mastectomy is the most common treatment. CONCLUSION: PAB is a rare and malignant cancer. We should pay attention to the diffuse progressive masses in the breast of young female, and perform MRI and biopsy if necessary. Mastectomy is the only treatment known that has proven to benefit these patients. There are no evidence-based guidelines regarding treatment.
format Online
Article
Text
id pubmed-10173155
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-101731552023-05-12 Primary angiosarcoma of breast: A case report and literature review Li, Min Yin, Ke Chen, Lin Shang, Xingchen Yang, Qing Tian, Xingsong Int J Surg Case Rep Case Report INTRODUCTION AND IMPORTANCE: Primary angiosarcoma of breast (PAB) is a rare and aggressive malignancy with limited published literature. This article aims to disclose the diagnosis and treatment of this case, review previous case reports, and provide clinical experience to breast surgeons. CASE PRESENTATION: A 36-year-old Asian female presented with a diffuse mass growing rapidly in her left breast. The ultrasonography (USG) suspected granulomatous mastitis. The core needle biopsy (CNB) confirmed the diagnosis of breast angiosarcoma (AS). She underwent mastectomy without axillary lymph node dissection (ALND) followed by adjuvant chemotherapy. About 11 months after mastectomy, the patient had bone metastasis. CLINICAL DISCUSSION: PAB is a rare vascular neoplasia, characterized by aggressive patterns, poor prognosis, and high malignant potential. It is difficult to diagnose or differentiate only by clinical or imaging examination. Biopsy and immunohistochemical staining are the most reliable method. Mastectomy is the most common treatment. CONCLUSION: PAB is a rare and malignant cancer. We should pay attention to the diffuse progressive masses in the breast of young female, and perform MRI and biopsy if necessary. Mastectomy is the only treatment known that has proven to benefit these patients. There are no evidence-based guidelines regarding treatment. Elsevier 2023-04-20 /pmc/articles/PMC10173155/ /pubmed/37120900 http://dx.doi.org/10.1016/j.ijscr.2023.108219 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Li, Min
Yin, Ke
Chen, Lin
Shang, Xingchen
Yang, Qing
Tian, Xingsong
Primary angiosarcoma of breast: A case report and literature review
title Primary angiosarcoma of breast: A case report and literature review
title_full Primary angiosarcoma of breast: A case report and literature review
title_fullStr Primary angiosarcoma of breast: A case report and literature review
title_full_unstemmed Primary angiosarcoma of breast: A case report and literature review
title_short Primary angiosarcoma of breast: A case report and literature review
title_sort primary angiosarcoma of breast: a case report and literature review
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173155/
https://www.ncbi.nlm.nih.gov/pubmed/37120900
http://dx.doi.org/10.1016/j.ijscr.2023.108219
work_keys_str_mv AT limin primaryangiosarcomaofbreastacasereportandliteraturereview
AT yinke primaryangiosarcomaofbreastacasereportandliteraturereview
AT chenlin primaryangiosarcomaofbreastacasereportandliteraturereview
AT shangxingchen primaryangiosarcomaofbreastacasereportandliteraturereview
AT yangqing primaryangiosarcomaofbreastacasereportandliteraturereview
AT tianxingsong primaryangiosarcomaofbreastacasereportandliteraturereview